Clinical Trial Update: Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety of fondaparinux for routine VTE prophylaxis in medical ICU patients; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Fondaparinux (fondaparinux)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Venous Thromboembolism | Phase 3 | Status: TERMINATED